Winyan
Analyst
Guggenheim Securities
Equibles does not estimate personal net worth.
About Winyan
Winyan is recorded as Analyst at Guggenheim Securities. Winyan has spoken on 1 earnings call across 1 company, most recently for Palvella Therapeutics, Inc. on May 7, 2026. The companies whose calls Winyan spoke on are classified in the Healthcare sector.
Winyan on recent calls
“First is, repamycin is supported by a substantial body of literature demonstrating efficacy, yet its clinical use has been constrained by the absence of well-defined treatment guidelines.”
Affiliation history
-
Guggenheim Securities
Analyst
Transcript header (unverified)
Current